Abstract Genetic manipulation of geldanamycin (GDM) producer Streptomyces species is a rational approach to understand biosynthesis processes and create new analogues. In this study, the carbamoyltransferase gene gdmN was inactivated by insertion of an apramycinresistance gene aac3 (IV) into the genome of the geldanamycin-producing strain Streptomyces hygroscopicus 17997. GDM analogues produced by this mutant strain were isolated and characterized, such as new compound 4,5-dihydro-7-O -descarbamoyl-7-hydroxy-19-Oglycylgeldanamycin. This compound could be converted to compound 4,5-dihydro-19-O-glycylgeldanamycin, another new GDM analogue, by a strain of Streptomyces hygroscopicus 17997 in which the GDM-pks was inactivated. These new compounds exhibited reductions of cytotoxicity against HepG2 cancer cells, but increases of aqueous solubility. These results suggest that a new postpolyketide synthase modification was involved in this process to produce new GDM analogues.
Introduction
Geldanamycin (GDM) produced by Streptomyces hygroscopicus has been identified as a novel heat shock protein 90 (Hsp90) inhibitor [1, 2] and is a promising drug candidate in combating human tumor [3] and viral diseases [4ϳ6] . Two GDM derivatives, the water-soluble 17-dimethylaminoethy-l7-demethoxygeldanamycin (17-DMAG) and 17-allylamino-17-demethoxy GDM (17-AAG), are currently in phase I and II clinical trials, respectively [7ϳ9] .
GDM is a 19-membered macrocyclic lactam that is related to the benzoquinone ansamycins, such as herbimycin and macbecin [10, 11] . Biosynthesis of this class of compounds involves the assembly of 3-amino-5-hydroxybenzoic acid as a starter unit. Following elongation with the acyl-Coenzyme A substrates malonyl-CoA, methylmalonyl-CoA, and 2-methoxymalonyl-CoA (ACP) [12ϳ14], the presumed polyketide intermediate undergoes intramolecular lactamization by GdmF to form progeldanamycin [15] , an initial polyketide synthase (PKS) product, which is, then converted to GDM by several post-PKS modification steps, such as C-17 hydroxylation, C-17 O-methylation, C-21 oxidation, C-7 carbamoylation, and C-4, 5 oxidation [15ϳ17].
A set of type I PKS genes required for GDM biosynthesis have been cloned, sequenced and analyzed from several Streptomyces spp. [15, 19, 20] . Analysis of the GDM biosynthetic gene cluster has revealed the presence of a series of putative post-PKS modifying genes from S. hygroscopicus var. geldanus NRRL 3602 [15] . The genetic manipulation of the gene or domain of the GDM biosynthetic gene cluster is helpful for understanding the biosynthesis process, and creates new analogues of GDM [16, 18] .
Our previous studies showed that the GDM biosynthetic gene cluster from GDM-producing strain S. hygroscopicus 17997 (GenBank accession number: AY179507) exhibited 93% identity to gdmN in NRRL 3602 [19] . BLAST search analysis indicated that GdmN is highly homologous to Ocarbamoyltransferases, NovN, Asm21 and ORF7 [21ϳ23], which are involved in the biosynthesis of novobiocin, ansamitocin and concanamycin A, respectively.
Here we report that the gdmN in S. hygroscopicus 17997 was inactivated by insertion of an apramycin-resistance gene, aac3 (IV) [24] , and that the known GDM analogue 4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin and new analogue 4,5-dihydro-7-O-descarbamoyl-7-hydroxy-19-O-glycylgeldanamycin were isolated from this gdmN inactivation strain. The C-7 O-carbamoylation of GDMCT-1-1 was successfully occurred by bioconversion with a gdmN gene-harboring strain. On the basis of the present results, we proposed that a new post-polyketide synthase modification was involved in this process to produce new GDM analogues.
Materials and Methods
Bacterial Strains, Plasmids and Culture Conditions GDM-producing strain S. hygroscopicus 17997 was isolated from soil in China (Institute of Medicinal Biotechnology, Beijing). A GDM-pks inactivation strain was constructed by Dr. Weiqing He (Institute of Medicinal Biotechnology, Beijing) [25] . pGH112 vector was kindly provided by Prof. Keqian Yang (Institute of Microbiology, Chinese Academy of Sciences, Beijing) [26] . Escherichia coli ET12567/pUZ8002 was used as donor strain for conjugal transfer to S. hygroscopicus 17997. pUC18-Am R (apramycin resistance) used for gene inactivation was constructed in our lab [19] and pKC1139-Km R (kanamycin resistance) used in the complementation experiment was generated by insertion of a 1.0-kb BamHI -EcoRI fragment from pUC119-kan R (provided by Prof. Huarong Tan, Institute of Microbiology, Chinese Academy of Sciences, China) into the same sites of pKC1139. E. coli ET12567/pUZ8002 and S. hygroscopicus 17997 were cocultured in Mannitol soya flour medium (MS) [27] . Media for the culture and fermentation of S. hygroscopicus 17997 were used as described by Gao et al. [28] .
Construction of Plasmids, PCR Primers and Conditions
An internal 949-bp EcoRI -BamHI fragment (fragment 1) and a 963-bp PstI -XbaI fragment (fragment 2) in gdmN gene were obtained by PCR using primers N1ϳN4: N1 (fragment 1) (5Ј-CCGGAATTCACGGCCTTGGCCA-GATCC-3Ј EcoRI), N2 (fragment 1) (5Ј-CGC-GGATCCATCCACCCCGCCTCGCAC-3Ј BamHI), N3 (fragment 2) (5Ј-AAAACTGCAGGCCGTTGAGGC-TGGAGTT-3Ј PstI), and N4 (fragment 2) (5Ј-CTA-GTCTAGACCGACTGGTTTGGGTGAT-3Ј XbaI). The fragment 1 and 2 were then ligated with a 1.5-kb BamHIPstI fragment carrying the apramycin-resistance gene from pUC18-Am R and then cloned into the EcoRI -XbaI sites of vector pGH112, to generate the replacement vector pGEXgdmN (Fig. 1) . For gene complementation, a BglII fragment of the intact gdmN gene was cloned in the pKC1139-Km R plasmid to generate the vector pKC-gdmN.
PCR reactions were performed with S. hygroscopicus 17997 and gdmN gene inactivation mutant genomic DNA as templates at 96°C for 4 minutes, followed by 30 cycles of 40 seconds at 94°C and 40 seconds at 59ϳ62°C, 1.5 minutes at 72°C, and an additional 5 minutes at 72°C. The PCR products were analyzed and purified with agarose gel and PCR Clean-Up System (Promega), as described by the manufacturer.
Isolation and Identification of gdmN Gene Mutant Strain
Plasmid pGEX-gdmN was introduced into S. hygroscopicus 17997 by conjugation using E. coli ET12567/PUZ8002 as a donor. Conjugation was carried out on MS agar plates incubating at 28°C for 20 hours. Transconjugants were selected after overlaying the plates with 1.0 ml H 2 O containing 200 m g/ml nalidixic acid and 50 m g/ml apramycin. Plates were incubated at 28°C for 7ϳ10 days. Single colonies were picked and grown on MY agar plates (4.0 g yeast extract, 10 g malt extract, 4.0 g glucose, 15 g agar, per liter) for several rounds of non-selective incubation. Desired double crossover mutants (Tsr S and Am R ) were obtained. To confirm the integration of the Am R gene into the gdmN locus, genomic DNA was isolated from a number of transconjugants, and PCR was carried out using primers P1 (5Ј-CCCAAGCTTCTCGTGGACGGG-TTGCT-3Ј) and P2 (5Ј-CTAGTCTAGATCGAACGCC-TCCACCTC-3Ј).
Fermentation and Purification
The gdmN mutant strain and gene complementation strain were grown on MY agar plates for 7 days for sporulation. Cultures were grown in seed medium for 2 days at 28°C, and 3.0 ml was used to inoculate 50 ml of fermentation medium in 500-ml shake flasks, which were cultured at 200 rpm at 28°C for another 3 or 4 days. Fermentation broth was extracted with EtOAc, and the extract was dried to a crude solid by rotary evaporation at 37°C. 
Complementation of gdmN Gene Plasmid pKC-gdmN was introduced to the gdmN inactivation strain by conjugation. gdmN gene complementation strains were grown in fermentation medium containing apramycin (50 m g/ml) and kanamycin (50 mg/ml). Culture broth was extracted with ethyl acetate and analyzed by HPLC.
HPLC was carried out by a Shimadzu LC-6A with a diode array UV detector set at 304 nm, fitted with a Diamonsil TM RP-C18 column (5.0 m m; 4.6ϫ150 mm). Samples were eluted with a gradient (1.0 ml/minute) of MeOH/H 2 O (40 : 60 to 100 : 0) over 30 minutes.
Non-enzymatic Conversion Experiment of GDMCT-1-7
10 m l of purified GDMCT-1-7 (80 mg/ml in DMSO) was incubated with 50 ml fermentation medium in 500-ml shake flasks at 200 rpm at 28°C for 3 days. Samples were monitored daily by HPLC and TLC analyzes.
Bioconversion and Purification
The GDM-pks inactivation strain was grown on MY agar plates for 7 days for sporulation. Culture was grown in seed medium for 2 days at 28°C, then 5.0 ml seed culture with addition of 10 m l GDMCT-1-1 (80 mg/ml in DMSO) was transferred into 50 ml fermentation medium in 500-ml shake flasks and incubated at 200 rpm at 28°C for 4 days. 4.0 liters fermentation broth was extracted twice with EtOAc and the extract was dried to a crude solid by rotary evaporation at 37°C. Fractionation was initiated by silica gel chromatography using CH 2 
Cytotoxicity Assay of GDM Analogues
The compounds were dissolved in DMSO as 100 mg/ml stock solutions before use and stored at Ϫ20°C. Human liver cancer HepG2 cells (the American Type Culture Collection, Rockville, MD) were cultured in MEM medium supplemented with 10% Fetal Bovine Serum. HepG2 cells were maintained in a 37°C, 5.0% CO 2 humidified incubator. For cytotoxicity assays, 5000 of HepG2 cells were plated in 100 m l per well into 96-well micro titer plates. Cells were allowed to adhere for 24 hours. Each compound ranging from 0.1 to 100 m g/ml in 100 m l was added to cells in duplicate wells. After 24 hours incubation, cell viability was determined by sulforhodamine B (SRB) assay [29] . IC 50 is defined as the concentration of compounds required for inhibiting cell growth by 50%.
Water Solubility Test of GDM Analogues
Standard curves of relationship between OD251 and OD304 values and concentrations of GDM analogues in MeOH were established. Saturated aqueous solution of GDM analogues was made in 50 mM PBS at pH 7.0 with magnetic stir at room temperature for 12 hours in dark, and then centrifuged at 100,000 g for 10 minutes at 4°C. Supernatant were measured by BECKMAN DU ® 800 nucleic acid/protein analyzer at OD251 (GDMCT-1-1 and GDMCT-1-2) and OD304 (GDMCT-1-7 and GDM). The concentration of the saturated aqueous solutions was determined according to standard curves.
Results

Inactivation of gdmN Gene
Inactivation of gdmN in S. hygroscopicus 17997 was performed by insertion of the Am R gene into the gdmN locus as shown in Fig. 1 , and confirmed by PCR analysis using P1 and P2 primers. Predicted sizes (3.1-kb and 4.5-kb) of PCR products were obtained using the genome DNA of S. hygroscopicus 17997 and gdmN inactivation strain as templates, respectively. Complementation analysis was performed to ensure the phenotypic change of the gdmN inactivation strain was solely caused by the inactivation of gdmN.
HPLC analysis showed that the ability of GDM production was completely lost by gdmN inactivation (Fig.  2B ) and restored by its complementation (Fig. 2C) . In contrast, two major components (GDMCT-1-1 and GDMCT-1-7) with Rt 12.9 and 25.8 minutes were observed in the gdmN inactivation strain (Fig. 2B) . It is interesting to note that the ratio of GDMCT-1-1 and GDMCT-1-7 produced by the gdmN inactivation strain was changed in a time dependent manner. As shown in Fig. 3 , GDMCT-1-7 was produced early and then gradually declined after 3 days fermentation, meanwhile GDMCT-1-1 had significantly accumulated during day 4 and day 5.
Structural Elucidation of GDMCT-1-7 and GDMCT-1-1
Compound GDMCT-1-7 displayed ESI-MS patterns resembling those of GDM. The 1 H-NMR, 13 C-NMR and MS data were identical with those of compound 3 [20] and were consistent with the molecular formula C 28 H 41 N 1 
O 8 obtained by negative HRFAB-MS ([MϪH]
Ϫ , m/z
518.2740). Accordingly, this compound is the 4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin (GDMCT-1-7)
being the main product of the carbamoyltransferase gene inactivation strain of S. hygroscopicus JCM4427 as reported by Hong et al. [20] . An analysis of the 1D and 2D NMR spectra of GDMCT-1-1 suggested that it is a derivative of GDM. From the 1 Hand 13 C-NMR spectra of GDMCT-1-1, the upfield shift of C-7 signals at d H 3.87 and d C 79.69 indicated that GDMCT-1-1 has a free hydroxyl group at C-7 rather than a carbamoyl group, as expected. Furthermore, two olefinic methine signals (C-4 and C-5) of GDMCT-1-1 were not detected, suggesting that its cis double bond had been hydrogenated. The signal of C-19 hydrogen was not detected, but an additional carbonyl signal (d C 165.52) and a secondary carbon (d C 29.21) hydrogen (d H 3.55) signal which has correlation with the C-19 carbon signal (d C 117.90) (Fig. 4) of the benzene ring as supported by HMQC (heteronuclear multiple quantum coherence) and HMBC (heteronuclear multiple bond coherence) spectra appeared, this suggesting that there is a O-glycyl group at C-19. A combination of COSY (combination of correlation spectroscopy), NOESY (nuclear overhauser effect spectroscopy), NMR and IR (infrared spectroscopy) data were used to assign the 1 H-and 13 C-NMR data unambiguously (Table 1) 
Microbial Conversion of GDMCT-1-1
In order to clarify the possible C-7 carbamoylation of GDMCT-1-1, a GDM-pks inactivation strain of S. hygroscopicus 17997, which did not produce GDM but retained the gdmN encoding enzyme activity, was used in the microbial conversion of GDMCT-1-1. The results indicated that a compound GDMCT-1-2 was detected with Rt 12.3 minutes by HPLC analysis (Fig. 3D) .
Compound GDMCT-1-2 displayed ESI-MS patterns that resembled those of GDMCT-1-1. An analysis of the 1D and 2D NMR spectra of GDMCT-1-2 suggested that it was a derivative of GDMCT-1-1. From the 1 H-and 13 C-NMR spectra of GDMCT-1-2, the upfield shift of C-7 signals at d H 4.86 and d C 81.92 indicated that GDMCT-1-2 had a carbamoyl group at C-7 rather than a free hydroxyl group (Fig. 4) , as expected; this was coincident with the new carbonyl C signal at d C 159.02. These results were consistent with the molecular formula C 31 H 45 N 3 O 11 Na obtained by positive HRFAB-MS (m/z 658.2972). A combination of COSY, HMQC, HMBC and NMR data were used to assign the 1 H-and 13 C-NMR data unambiguously (Table 1) . Compared to GDMCT-1-1, the structure of this new metabolite was elucidated as 4,5-dihydro-19-O-glycylgeldanamycin (GDMCT-1-2). C-NMR data of compound GDMCT-1-1 (500 MHz) and GDMCT-1-2 (600 MHz) Water Solubility and Cytotoxicity of GDM Analogues As shown in Table 2 , the results of the solubility assay showed that the solubility of GDMCT-1-1 and GDMCT-1-2 was approximately 23-fold higher than that of GDM in aqueous solution.
The cytotoxicity of the compounds against HepG2 cells was investigated. As shown in Table 2 , the results indicated that the cytotoxicity of GDMCT-1-1 and GDMCT-1-7 was almost 41 to 471-fold lower than that of GDM.
Discussion
To our best knowledge, this is the first report that GDMCT-1-1 and GDMCT-1-2 were produced by engineered biosynthesis. The new compound GDMCT-1-1 was purified from the fermentation broth of the gdmN inactivation strain, which was not detected in wild-type S. hygroscopicus 17997. It has been reported that this compound is not produced in the same gene (gel8) inactivation strain of S. hygroscopicus JCM4427 [20] .
It is notable that inactivation of gdmN gene in S. hygroscopicus 17997 resulted in production of GDMCT-1-1 (Fig. 3AϳC) . The accumulation of descarbamoylated compounds GDMCT-1-7 and GDMCT-1-1 in the gdmN inactivation strain of S. hygroscopicus 17997 confirmed that the gdmN encodes a carbamoyltransferase. We observed that GDMCT-1-7 was produced at an early stage, and then declined simultaneously with an increase of GDMCT-1-1 (Fig. 3AϳC) , suggesting that GDMCT-1-7 might serve as a precursor for the biosynthesis of GDMCT-1-1 at least in the gdmN inactivation strain of S. hygroscopicus 17997. GDMCT-1-1 could be converted to GDMCT-1-2 by the gdmN containing strain of S. hygroscopicus 17997.
In our study, GDMCT-1-1 was not monitored in the nonenzymatic conversion experiment of GDMCT-1-7 (data not shown), indicating that GDM C-19 modification enzymes (glycyltransferase or a bifunctional C-19 hydroxy/glycyltransferase) were possibly involved in GDMCT-1-1 biosynthesis in the gdmN inactivation strain of S. hygroscopicus 17997. It has been reported that an Nglycyltransferase is discovered in S. sannanensis IFO 14239 (sannamycin-producer), and the gene sequences of similar glycyltransferase have been detected in other aminoglycoside antibiotic producers by DNA hybridization [30] . Up to now, there has been no report that the biological modification of GDM analogues at C-19, although this position can be nonenzymatically modified by glutathione [31] . GDMCT-1-1 was not observed in the wild-type S. hygroscopicus 17997 strain, because its intermediate product (GDMCT-1-7, a possible substrate of the putative glycyltransferase) is rapidly carbamoylated by GdmN, and therefore is not available for latter glycylation reaction. The conversion of GDMCT-1-7 to GDMCT-1-1 in the gdmN inactivation strain fermentation process may suggest that this is likely a spurious cellular event caused by a series of enzymes that are not directly involved in the biosynthesis of GDM. The mechanism of the O-glycylation of GDMCT-1-7 C-19 will be investigated in further experiments of gene expression and purified enzymes.
It is interesting that the GDM analogues GDMCT-1-7, GDMCT-1-1 and some other precursors [32] can be recognized by C-7 carbamoylase, which indicates that the C-7 carbamoylation enzyme possesses a rather broad substrate specificity. GDMCT-1-1 and GDMCT-1-2 do not carry a double bond at the C-4 and C-5 positions, the possible reason for the inhibition of C-4, 5 oxidation of GDMCT-1-1 and GDMCT-1-2 is currently undergoing investigation. Taken together, we speculate a new post-PKS modification process of GDM analogue biosynthesis in S. hygroscopicus 17997 as described in Fig. 5 .
So far, the effective chemical modification of GDM is mostly restricted to one region of the compound, the C-17 position of the benzoquinone moiety [33ϳ35]. However, due to the occurrence of resistance and the hepatotoxicity of the current analogues, new GDM analogues with improved efficacy, reduced toxicity and favorable pharmacological profiles are in great demand [33, 36] . Consequently, clear understand of GDM biosynthesis and the discovery of new post-tailoring enzymes should be useful for the development of new analogues.
Although the two new compounds GDMCT-1-1 and GDMCT-1-2 showed reductions of cytotoxicity against HepG2 cells (Table 2) , they exhibited a notable increase of water-solubility relative to GDM and GDMCT-1-7 (Table  2) , which is an important characteristic for the innovation of GDM-derived compounds. Our results provide a new modification position of GDM and contribute to better understanding of GDM biosynthesis, and this would provide valuable information for the design of new GDM analogues with enhanced biological activity.
